Orthopedic experts, including AAOS, encourage relying on evidence-based treatments and caution against experimental treatments lacking proper validation, like BPC-157
Alzahrani and colleagues reported in 2025 that intravenous glutathione is associated with serious safety concerns like anaphylaxis and hepatotoxicity. Regulatory bodies have issued clear warnings: Philippine FDA (2025): The FDA has not approved any injectable products for skin lightening UK Trading Standards (June 2025): Public warning about dangerous glutathione IV drips No professional dermatology organization endorses IV glutathione for skin lightening purposes
When stored correctly and handled aseptically, bacteriostatic water is generally viable for up to 28 days following the first vial puncture
However, for long-term storage, it is recommended to store them in the freezer
Modulation of transforming growth factor-beta (TGF-beta), integrins, and stem cell pathways have also been observed
Maintain the 4-6 hour timing window